EP3089684B1 - Dilation system - Google Patents
Dilation system Download PDFInfo
- Publication number
- EP3089684B1 EP3089684B1 EP14828421.9A EP14828421A EP3089684B1 EP 3089684 B1 EP3089684 B1 EP 3089684B1 EP 14828421 A EP14828421 A EP 14828421A EP 3089684 B1 EP3089684 B1 EP 3089684B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- dilator
- bore
- elongated body
- distal end
- channel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000010339 dilation Effects 0.000 title claims description 51
- 239000000523 sample Substances 0.000 claims description 76
- 230000004936 stimulating effect Effects 0.000 claims description 73
- 210000002097 psoas muscle Anatomy 0.000 description 29
- 238000003780 insertion Methods 0.000 description 16
- 230000037431 insertion Effects 0.000 description 16
- 230000001537 neural effect Effects 0.000 description 16
- 210000005036 nerve Anatomy 0.000 description 14
- 210000001519 tissue Anatomy 0.000 description 14
- 230000008901 benefit Effects 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 239000000835 fiber Substances 0.000 description 8
- 238000001356 surgical procedure Methods 0.000 description 5
- 208000014674 injury Diseases 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- 238000002594 fluoroscopy Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 241001631457 Cannula Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 210000002988 lumbosacral plexus Anatomy 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- 150000002843 nonmetals Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910000811 surgical stainless steel Inorganic materials 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/02—Surgical instruments, devices or methods for holding wounds open, e.g. retractors; Tractors
- A61B17/0218—Surgical instruments, devices or methods for holding wounds open, e.g. retractors; Tractors for minimally invasive surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/012—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor characterised by internal passages or accessories therefor
- A61B1/018—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor characterised by internal passages or accessories therefor for receiving instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/32—Devices for opening or enlarging the visual field, e.g. of a tube of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/02—Surgical instruments, devices or methods for holding wounds open, e.g. retractors; Tractors
- A61B17/0293—Surgical instruments, devices or methods for holding wounds open, e.g. retractors; Tractors with ring member to support retractor elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
- A61B17/3421—Cannulas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
- A61B17/3421—Cannulas
- A61B17/3423—Access ports, e.g. toroid shape introducers for instruments or hands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/34—Trocars; Puncturing needles
- A61B17/3468—Trocars; Puncturing needles for implanting or removing devices, e.g. prostheses, implants, seeds, wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4887—Locating particular structures in or on the body
- A61B5/4893—Nerves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00039—Electric or electromagnetic phenomena other than conductivity, e.g. capacity, inductivity, Hall effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
- A61B17/3421—Cannulas
- A61B2017/3433—Cannulas with different outer diameters of the cannula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M29/00—Dilators with or without means for introducing media, e.g. remedies
Definitions
- inventive concepts disclosed and claimed herein relate to systems for performing surgical procedures and, more particularly, but not by way of limitation, to systems and methods for accessing a surgical target site to perform surgical procedures.
- the present state of the art when referencing a lateral surgical access approach, typically consists of using the following surgical instruments: neuromonitoring probe, dilators, and a retractor. Once an operative level is identified and an incision is created, dilators are used to create a surgical access site which is often followed by the use of a retractor or other specialized tools to create a surgical access corridor.
- a psoas muscle which is located on either side of the spine, is separated in order to access the spine and, in particular, an intervertebral disc space or one or more vertebral bodies within a patient's spinal column. It is desirable to avoid neural elements or nerves of the lumbar plexus that lie within the psoas muscle during such procedures.
- the anterior third of the psoas muscle is typically considered a safe zone for muscle separation.
- the neural elements or nerves of the psoas muscle may be mapped using a stimulating probe.
- the stimulating probe may then be inserted through the psoas muscle via the most posterior neural or nerve-free tissue area or through nearly any other region that is free of neural elements or nerves and toward the spine or into the intervertebral disc space in order to initiate safe tissue separation of the psoas muscle.
- Dilators are next placed over the probe to create and enlarge a surgical access site. Following the use of dilators, a retractor or other specialized tools are used to further enlarge the surgical access corridor.
- Concentric dilators separate the muscle radially, and as such, dilate tissue on all both sides of the stimulating probe in a uniform fashion. This in turn may impinge on neural elements or nerves located outside of the safe zone.
- Directional dilators have been suggested to overcome the problems associated with concentric dilators. While directional dilation systems are effective for avoiding known neural elements, they are limited in their ability to continuously monitor nerve proximity and to create a surgical access site of a desired shape while at the same time reducing the amount of tissue damage.
- US Patent Publication No. US-2011/208226 discloses a dilation system including sequential directional dilators or a blunt stimulating dilator with at least one channel formed therein.
- a stimulating probe is inserted through the psoas muscle toward the patient's spine.
- the directional sequential dilators are inserted to dilate the tissue on any side of the stimulating probe.
- the dilators are rendered directional by having bores, by means of which they can be inserted over each other and over the probe, which are offset from their longitudinal axes.
- US Patent Publication No. US-2010/145391 discloses a set of surgical cannulas.
- the terms “comprises,” “comprising,” “includes,” “including,” “has,” “having” or any other variation thereof, are intended to cover a non-exclusive inclusion.
- a process, method, article, or apparatus that comprises a list of elements or steps is not necessarily limited to only those elements or steps and may include other elements, steps, or features not expressly listed or inherently present therein.
- the terms "about,” “approximately,” and “substantially” are intended to signify that the item being qualified is not limited to the exact value specified, but includes some slight variations or deviations therefrom, caused by measuring error, manufacturing tolerances, stress exerted on various parts, wear and tear, or combinations thereof, for example.
- At least one will be understood to include one as well as any quantity more than one, including but not limited to each of, 2, 3, 4, 5, 10, 15, 20, 30, 40, 50, 100, and all integers therebetween.
- the term “at least one” may extend up to 100 or 1000 or more, depending on the term to which it is attached; in addition, the quantities of 100/1000 are not to be considered limiting, as higher limits may also produce satisfactory results. Singular terms shall include pluralities and plural terms shall include the singular unless indicated otherwise.
- any reference to "one embodiment” or “an embodiment” means that a particular element, feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment.
- the appearances of the phrase “in one embodiment” in various places in the specification are not necessarily referring to the same embodiment, although the inventive concepts disclosed herein are intended to encompass all combinations and permutations including one or more of the features of the embodiments described herein.
- dilation systems will be described in detail herein in connection with accessing the spine or performing a surgical procedure, but dilation systems according to the inventive concepts disclosed herein may find use in any desired orthopaedic or other surgical procedures in which a surgeon wishes to gain access to an internal cavity by cutting the skin and going through the body wall in order to keep the incision spread apart so that surgical instruments can be inserted in the internal cavity.
- dilation systems according to the inventive concepts disclosed herein may be used for anteriorly or posteriorly accessing the spine, for accessing the thoracic or cervical region of the spine, or for accessing any other part, cavity, or organ of the body of a human being or an animal.
- Embodiments of dilation systems according to the inventive concepts disclosed herein may be used to gradually and atraumatically dilate a surgical opening by sequentially inserting two or more serial dilators into the surgical opening and rotating the dilators to enlarge the surgical opening.
- the surgical opening may be enlarged by inserting a first dilator, rotating the first dilator, and inserting one or more second dilators over the first dilator, with each subsequent dilator being rotated to dilate the surgical opening.
- dilations systems according to the inventive concepts disclosed herein may include reduced diameter dilators with standard or fixed-size stimulating probes.
- the dilation system 100 includes a first or initial dilator 102, one or more second or intermediate dilators 104, and a third or final dilator 106 configured to be matingly coupled with one another around a longitudinal axis 108. It is to be understood that dilation systems according to the inventive concepts disclosed herein may include any desired number of dilators, such as two, three, four, or more dilators.
- the dilation system 100 is configured to be used in combination with a monitoring K-wire or stimulating probe, such stimulating probe 170 depicted in FIG. 9A , for transmitting an electrical pulse as described below.
- the first dilator 102 includes an elongated body 110 having a longitudinal axis 112, a proximal end 114 a distal end 116, and an outer surface 118.
- the elongated body 110 may include a bore 120.
- the elongated body 110 has a substantially elliptical transverse cross-section and includes a major axis 122 and a minor axis 124 which are substantially normal to one another (e.g., substantially perpendicular to one another).
- the elongated body 110 has a first diameter (e.g., a transverse diameter) along the major axis 122 and a second diameter (e.g., a conjugate diameter) along the minor axis 124, with the first diameter being greater than the second diameter.
- a first diameter e.g., a transverse diameter
- a second diameter e.g., a conjugate diameter
- the outer surface 118 may include at least one channel 126 formed therein and extending along the outer surface 118 from the proximal end 114 to the distal end 116.
- the channel 126 is configured to slidably receive a stimulating probe, such as a stimulating probe 170a depicted in FIG. 9B ).
- the channel 126 may extend along the outer surface 118 such that the channel 126 intersects the major axis 122 of the elongated body 110 in some embodiments.
- the channel 126 may intersect the minor axis 124, may be tangential or positioned adjacent to the major axis 122 or the minor axis 124, and/or may be positioned so as not to intersect either the major axis 122 or the minor axis 124.
- any number of channels 126 may be implemented with the first dilator 102 in some embodiments of the inventive concepts disclosed herein, such as two or more channels 126.
- one or more first channels 126 may intersect the major axis 122, and one or more second channels 126 may intersect the minor axis 124 as will be appreciated by persons of ordinary skill in the art having the benefit of the instant disclosure.
- the outer surface 118 may taper inwardly adjacent to the distal end 116 so that the first dilator 102 is configured to minimize trauma to tissues when the distal end 116 of the first dilator 102 is inserted into a tissue.
- the outer surface 118 may include a plurality of grasping notches 128 formed therein adjacent to the proximal end 114 of the elongated body 110.
- the grasping notches 128 may be configured to allow a surgeon to grip the first dilator 102 (e.g., manually or via a suitable surgical tool or robotic arm) and to manipulate the first dilator 102 as will be described below.
- the elongated body 110 of the first dilator 102 is sized relative to the second dilator 104 such that a portion of the elongated body 110 (e.g., the proximal end 114 and/or a portion of the outer surface 118 including the grasping notches 128) remains accessible when the dilation system 100 is assembled and used as will be described below.
- the bore 120 may extend through the elongated body 110 from the proximal end 114 to the distal end 116 and is configured to slidably receive a stimulating probe or a guide wire therein.
- the bore 120 is substantially aligned with the longitudinal axis 112.
- the bore 120 may be laterally offset from the longitudinal axis 112 or omitted.
- the bore 120 is shown as being substantially cylindrical in shape, the bore 120 may have any desired shape, size, and cross-section in some embodiments of the inventive concepts disclosed herein.
- an embodiment of a first dilator 102a may be implemented similarly to the first dilator 102 and may include a bore 120a which is offset from the longitudinal axis 112a.
- the first dilator 102 may be constructed of any desired material, such as stainless steel, surgical steel, titanium, metals, anodized aluminium, non-metals, polyether ether ketone (PEEK), polymers, resins, or combinations thereof, and may be constructed using any desired manufacturing technique, such as machining, casting, molding, or combinations thereof.
- the first dilator 102 may be provided visual or haptic depth markings (e.g., along the outer surface 118) to indicate an appropriate insertion depth to a surgeon as will be appreciated by persons of ordinary skill in the art having the benefit of the instant disclosure.
- the second dilator 104 may be implemented similarly to the first dilator 102 and includes an elongated body 130 having a longitudinal axis 132, a proximal end 134, a distal end 136, an outer surface 138 extending between the proximal end 134 and the distal end 136, and a bore 140 extending from the proximal end 134 to the distal end 136.
- the elongated body 130 has a substantially elliptical transverse cross-section and includes a major axis 142 and a minor axis 144 being substantially normal (e.g., substantially perpendicular) to the major axis 142.
- the elongated body 130 has a first diameter (e.g., a transverse diameter) along the major axis 142 and a second diameter (e.g., a conjugate diameter) along the minor axis 144, with the first diameter being greater than the second diameter.
- a first diameter e.g., a transverse diameter
- a second diameter e.g., a conjugate diameter
- the bore 140 is sized, shaped, and configured to matingly and slidably receive the first dilator 102 therein so that the major axis 142 of the second dilator 104 is aligned with the minor axis 124 of the first dilator 102 and the minor axis 144 of the second dilator 104 is aligned with the major axis 122 of the first dilator 102.
- the outer surface 138 has at least one channel 146 for receiving a stimulating probe, the channel 146 extending from the proximal end 134 to the distal end 136 and intersecting the major axis 142 of the elongated body 130. It is to be understood that in some embodiments, the channel 146 may intersect the minor axis 144, may be tangential or positioned adjacent to the major axis 142 or the minor axis 144, and/or may be positioned so as not to intersect either the major axis 142 or the minor axis 144. Further, any number of channels 146 may be implemented with the second dilator 104 in some embodiments of the inventive concepts disclosed herein, such as two or more channels 146.
- one or more channel 146 may intersect the major axis 142, and one or more channel 146 may intersect the minor axis 144 as will be appreciated by persons of ordinary skill in the art having the benefit of the instant disclosure.
- the outer surface 138 may taper adjacent to the distal end 136 so as to facilitate insertion into tissue.
- the general shape of the first dilator 102 is atraumatic.
- the outer surface 138 may include a plurality of grasping notches 148 formed therein adjacent to the proximal end 134 of the elongated body 130.
- the grasping notches 148 may be configured to allow a surgeon to grip the second dilator 104 (e.g., manually or via a suitable surgical tool) and to manipulate the second dilator 104 as will be described below.
- the elongated body 130 of the second dilator 104 is sized relative to the third dilator 106, such that a portion of the elongated body 130 (e.g., the proximal end 134 and/or a portion of the outer surface 138 including the grasping notches 148) remains accessible when the dilation system 100 is assembled and used as will be described below.
- any desired number of second or intermediate dilators 104 may be implemented with the dilation system 100, such as one, two, three, or more of the second dilators 104.
- each successive second dilator 104 may have a bore 140 configured to matingly (e.g., slidably) receive a preceding second dilator 104 therein such that the major axis 142 of one of the preceding second dilator 104 is substantially aligned with a minor axis 144 of the successive second dilator 104 and the minor axis 144 of the preceding second dilator 104 is substantially aligned with the major axis 142 of the successive second dilator 104.
- the third dilator 106 may be implemented similarly to the first dilator 102 and includes an elongated body 150 having longitudinal axis 152, a proximal end 154, a distal end 156, an outer surface 158 extending between the proximal end 154 and the distal end 156, and a bore 160 extending from the proximal end 154 to the distal end 156.
- the elongated body 150 is illustrated as having a substantially circular transverse cross-section and is configured so as to allow the third dilator 106 to interface with a retractor, such as a multi-blade retractor in some embodiments.
- the outer surface 158 may include at least one channel 166 for receiving a stimulating probe therein.
- the channel 166 may extend from the proximal end 154 to the distal end 156 and may be positioned so as to intersect the minor axis 144 of the elongated body 130 when the second dilator 104 is matingly received in the third dilator 106. It is to be understood that in some embodiment the channel 166 may be tangential or positioned adjacent to the major axis 142 and/or may be spaced a distance from the major axis 142. Further, any number of channels 166 may be implemented with the third dilator 106 in some embodiments of the inventive concepts disclosed herein, such as two or more channels 166.
- the outer surface 158 may taper adjacent to the distal end 156 so as to facilitate insertion into tissue.
- the general shape of the second dilator 104 is atraumatic.
- the outer surface 158 may include a plurality of grasping notches 159 formed therein adjacent to the proximal end 154 of the elongated body 150.
- the grasping notches 159 may be configured to allow a surgeon to grip the third dilator 106 (e.g., manually or via a suitable surgical tool) and to manipulate the third dilator 106 as described below.
- the bore 160 has a substantially elliptical transverse cross-section and includes a major axis 162 and a minor axis 164, which may be substantially normal to one another.
- the bore 160 has a first diameter (e.g., a transverse diameter) along the major axis 162 and a second diameter (e.g., a conjugate diameter) along the minor axis 164, with the first diameter being greater than the second diameter.
- the bore 160 is configured to matingly and slidably receive the second dilator 104 therein such that the major axis 142 of the elongated body 130 is aligned with the major axis 162 of the bore 160 and such that the minor axis 144 of the elongated body 130 is aligned with the minor axis 164 of the bore 160.
- the third dilator 106 may be omitted, while in some embodiments multiple third dilators 106 may be implemented, with each successive third dilator 106 having a bore 160 configured to matingly receive a preceding third dilator 106 therein.
- FIGS. 9A-9F an exemplary embodiment of a method of using the dilation system 100 to access a lumbar region of a spine via a lateral approach will be described herein. The method does not fall within the scope of the invention as claimed. A similar or the same method may be used with the dilation system 100 in other parts of a patient's body.
- a surgeon may map a safe zone (e.g., a zone generally free of neural elements or nerves) on a tissue of interest (e.g., psoas muscle). For example, on a human psoas muscle, the anterior third of the psoas muscle is generally considered a safe zone. Once a safe zone is established, anatomical placement may be confirmed via intra-operative fluoroscopy.
- a safe zone e.g., a zone generally free of neural elements or nerves
- anatomical placement may be confirmed via intra-operative fluoroscopy.
- the surgeon inserts the stimulating probe 170 through the psoas muscle toward the patient's spine, as shown in FIG. 9A . If the surgery is being performed on the intervertebral disc space, the distal end of the stimulating probe 170 may be inserted into the annulus of the desired intervertebral disc space or may be positioned so that a tip of the stimulating probe 170 is proximate to the patient's spine 174.
- the stimulating probe 170 may be inserted via the most posterior portion of the safe zone in some embodiments.
- the surgeon may insert or slide the first dilator 102 over the stimulating probe 170 (e.g., such that the stimulating probe 170 is slidably received in the bore 120 of the first dilator 102) and may insert the distal end 116 and/or a portion of the elongated body 110 of the first dilator 102 through the psoas muscle 172 and toward the patient's spine 174.
- the first dilator 102 may be inserted through the psoas muscle without the use of a stimulating probe or guide wire.
- the first dilator 102 is inserted into the psoas muscle 172 such that the major axis 122 is oriented substantially parallel to the prevalent direction or orientation of psoas muscle fibers 176 adjacent to the insertion site and the minor axis 124 is oriented substantially perpendicular to the prevalent direction or orientation of psoas muscle fibers 176 adjacent to the insertion site.
- an additional or secondary stimulating probe 170a may be inserted into the channel 126 to allow the surgeon determine the proximity of neural elements or nerves.
- the surgeon may then rotate the first dilator 102 about the longitudinal axis 112 about 90° or about 270° (e.g., clockwise or counter clockwise) such that the major axis 122 is substantially perpendicular to the prevalent direction or orientation of psoas muscle fibers 176 adjacent to the insertion site and such that the minor axis 124 is substantially parallel to the prevalent direction or orientation of psoas muscle fibers 176 adjacent to the insertion site
- the stimulating probe 170a may be utilized before, during, and/or during rotating the first dilator 102 to transmit one or more electrical pulses via an EMG into the stimulating probe to determine the proximity of neural elements or nerves.
- the first dilator 102 may be rotated so as to complete one or more rotations about the longitudinal axis 112 to enable the surgeon to locate a safe zone and/or determine the proximity of neural elements or nerves via the stimulating probe 170a.
- the insertion site is dilated or enlarged by the rotation of the first dilator 102 as a result of the major axis 122 of the first dilator 102 being greater than the minor axis 124 thereof.
- the stimulating probe 170a may be removed from the first dilator 102 after the first dilator 102 is rotated as described above.
- the surgeon can insert the second dilator 104 over the first dilator 102 and towards the patient's spine 174 by receiving the first dilator 102 in the bore 140 of the second dilator 104 in a way that the minor axis 144 of the second dilator 104 is aligned with the major axis 122 of the first dilator 102 the major axis 142 of the second dilator 104 is aligned with the minor axis 124 of the first dilator 102.
- This arrangement of the second dilator 104 relative to the first dilator 102 results in the distal end 136 of the second dilator 104 being initially inserted into the psoas muscle 172 so that the minor axis 144 of the second dilator 104 is oriented substantially perpendicular to the prevalent direction or orientation of psoas muscle fibers 176 adjacent to the insertion site and the major axis 142 is substantially parallel to the prevalent direction or orientation of psoas muscle fibers 176.
- the stimulating probe 170a may be inserted into the channel 146 to allow the surgeon to determine the proximity of neural elements or nerves.
- the surgeon may rotate the second dilator 104 about the longitudinal axis 132 about 90° or about 270° (e.g., clockwise or counter clockwise) such that the major axis 142 is substantially perpendicular to the prevalent direction or orientation of psoas muscle fibers 176 adjacent to the insertion site and such that the minor axis 144 is substantially parallel to the prevalent direction or orientation of psoas muscle fibers 176 adjacent to the insertion site.
- the stimulating probe 170a may be utilized before, during, and/or during rotating the second dilator 104 to transmit one or more electrical pulses via an EMG into the stimulating probe 170a to determine the proximity of neural elements or nerves.
- the second dilator 104 may be rotated so as to complete one or more rotations about the longitudinal axis 132 to enable the surgeon to determine the proximity of neural elements or nerves via the stimulating probe 170a.
- the stimulating probe 170a may be removed after the second dilator 104 is rotated as described above.
- the first dilator 102 is matingly received in the bore 140 of the second dilator 104 such that the second dilator 104 and the first dilator 102 move as a unit when the second dilator 104 is rotated.
- the insertion site is further dilated or enlarged by the rotation of the second dilator 104 as a result of the major axis 142 of the second dilator 104 being larger than the minor axis 144 of the second dilator 104.
- the surgeon can insert one or more second or intermediate dilators 104 in a similar manner and rotating each successive second dilator 104 about 90° or about 270° (e.g., clockwise or counter clockwise) after insertion.
- the surgeon can insert the third or final dilator 106 over the second dilator 104, for example, by slidably receiving the second dilator 104 in the bore 160 of the third dilator 106 such that the major axis 142 of the second dilator 104 is aligned with the major axis 162 of the bore 160 and the minor axis 144 is aligned with the minor axis 164 of the bore 160.
- the second dilator 104 is matingly received in the bore 160 of the third dilator 106 such that the third dilator 106 and the second dilator 104 move as a unit when the third dilator 106 is rotated.
- the stimulating probe 170a may be inserted into the channel 166 to allow the surgeon to determine the proximity of neural elements or nerves by transmitting one or more electrical pulses via an EMG into the stimulating probe.
- the surgeon may rotate the third dilator 106 between about 0° and about 360° (clockwise or counter clockwise) about the longitudinal axis 152 to enable the surgeon to determine the proximity of neural elements or nerves by transmitting one or more electrical pulses via an EMG into the stimulating probe 170d.
- the third dilator 106 may interface with a retractor (not shown) that can be inserted over the third dilator 106 to subsequently retract the tissue and to permit removal of the dilation system 100 and the stimulating probes 170 and 170a.
- an external diameter of the dilators of dilation systems dictates the size of retractors that can be used with the particular dilation system.
- the retractors have a relatively small diameter, generally smaller dilators are used to dilate the muscle prior to inserting the retractor.
- smaller diameter dilators may not have a sufficient thickness to accommodate a probe channel therein. This problem is especially relevant to the diameters of second and subsequent sequential dilators that are inserted over one another in a sequence.
- the first dilator may have an overall diameter configured to be as small as possible while still allowing the first dilator to accommodate a stimulating probe bore or channel therein.
- the second and subsequent dilators may be modified such that a portion of the respective stimulating probe channels extend into a bore for receiving the preceding dilator, thus resulting in a reduced overall diameter of each dilator and of the dilation system as a whole, while using a standard or fixed size stimulating probe.
- the dilation system 100a includes a first or initial dilator 180, a second or intermediate dilator 182, and a third or final dilator 184.
- the dilation system 100a may be configured to be used in combination with a monitoring K-wire or stimulating probe for transmitting an electrical pulse as described above.
- the first dilator 180 includes an elongated body 188 having a longitudinal axis 190, a bore 192, and an outer surface 194.
- the elongated body 188 can be implemented similarly to the elongated body 110.
- the bore 192 may be implemented similarly to the bore 120 and is sized and configured to slidably receive a stimulating probe, such as the stimulating probe 170. In one embodiment, the bore 192 may be omitted from the elongated body 110.
- the outer surface 194 has a substantially circular transverse cross-section but includes a channel 196, a keying slot 198, and a groove 200.
- the outer surface 194 may taper at a distal end of the elongated body 188 to facilitate insertion into tissue.
- the general shape of the first dilator 180 is atraumatic.
- the channel 196 may be implemented similarly to the channel 126 and is configured to slidably receive a stimulating probe therein, such as the stimulating probe 170a.
- the keying slot 198 is configured to receive a keying pin therein so as to key the orientations of the first dilator 180 and the second dilator 182 relative to one another. It is to be understood that the keying slot 198 may have any desired shape, size, or cross-section and may be located adjacent to a proximal end of the elongated body 188 or may extend partially or substantially completely along the outer surface 194 of the elongated body 188 in some embodiments so as to not cause trauma to tissues or interfere with dilating a surgical opening during use of the first dilator 180.
- the groove 200 is formed in the outer surface 194 and extends along the elongated body 188 such that the groove 200 may be aligned with a corresponding groove formed in the second dilator 182 as described below so as to form a combined lateral bore 202 ( FIG. 10 ) for receiving a stimulating probe (e.g., the stimulating probe 170a).
- the groove 200 is formed in the outer surface 194 so that the groove 200 is offset from the channel 196 at any desired distance or angle.
- the groove 200 is diametrically opposed to the channel 196 along the outer surface 194, however, in some embodiments the groove 200 may be adjacent to, tangential to, or positioned at any desired location along the outer surface 194 relative to the channel 196.
- the second dilator 182 includes an elongated body 204 having a bore 206, and an outer surface 208.
- the bore 206 includes a groove 210 and a keying pin 212 formed therein and is sized, shaped, and configured to matingly and slidably receive the first dilator 180 therein so that the groove 210 aligns with the groove 200 of the first dilator 180 when the first dilator 180 is matingly received in the bore 206 such that the groove 210 and the groove 200 cooperate with one another to define the lateral bore 202 ( FIG. 10 ) for receiving a stimulating probe, such as the stimulating probe 170a.
- a stimulating probe such as the stimulating probe 170a.
- the grooves 200 and 210 are configured so that when a stimulating probe, such as the stimulating probe 170a is inserted into the lateral bore 202, a portion of the stimulating probe 170 is received in the groove 200 and a portion of the stimulating probe 170 is received in the groove 210.
- the diameter of the stimulating probe 170a may be about 3 mm, while the general thickness of the elongated body 206 may in a range from about 1 mm to about 3 mm.
- the keying pin 212 is configured to be matingly received in the keying slot 198 such that the first dilator 180 is matingly received in the second dilator 182 so that the groove 210 aligns with the groove 200 to form the lateral bore 202.
- the outer surface 208 includes a groove 214 and a keying slot 216.
- the outer surface 208 may be tapered at a distal end of the elongated body 204 to facilitate insertion into tissue.
- the general shape of the second dilator 182 is atraumatic.
- the groove 214 may be implemented similarly to the groove 200 and extends along the elongated body 204, such that the groove 214 may be aligned with a corresponding groove formed in the third dilator 184 as described below so as to form a lateral bore 218 ( FIG. 10 ) for receiving a stimulating probe therein.
- the groove 214 may be formed at any desired location in the outer surface 208. In some examples, the groove 214 may be positioned along the outer surface 208 so that the groove 214 aligns with the channel 196 when the first dilator 180 is matingly received by the second dilator 182.
- the keying slot 216 may be implemented similarly to the keying slot 198 and is configured re receive a keying pin therein.
- the keying slot 216 may be positioned at any desired location and may be offset from the groove 214, the keying pin 212, and the groove 210 in some examples.
- the third dilator 184 may be implemented similarly to the third dilator 106 and includes an elongated body 220 having a bore 222 and an outer surface 224.
- the bore 222 may be implemented similarly to the bore 206 and includes a groove 226 and a keying pin 228.
- the bore 222 is configured to matingly receive the second dilator 182 therein so that the groove 226 aligns with the groove 214 of the second dilator 182 when the second dilator 182 is matingly received in the bore 222 such that the groove 226 and the groove 214 cooperate with one another to define the lateral bore 218 ( FIG. 10 ) for receiving a stimulating probe such as the stimulating probe 170 therein.
- the diameter of the stimulating probe 170a may be about 3 mm, while the general thickness of the elongated body 220 may in a range from about 1 mm to about 3 mm.
- the keying pin 228 is matingly received in the keying slot 216 of the second dilator 182 so as to align the second dilator 182 and the third dilator 184 relative to one another as described above.
- the outer surface 224 is configured so that the third dilator 184 interfaces with a retractor to subsequently retract the tissue and to permit removal of the dilation system 100a and the stimulating probes.
- the dilation system 100a may be implemented with any number of dilators for example two, three, four, or more.
- the dilation system 100b includes a first or initial dilator 230, a second or intermediate dilator 232, and a third or final dilator 234 configured to be matingly coupled with one another.
- the dilation system 100b is configured to be used in combination with a monitoring K-wire or stimulating probe, such as the stimulating probe 170, for transmitting an electrical pulse.
- the first dilator 230 includes an elongated body 240 having a longitudinal axis 242, a bore 244, and an outer surface 246.
- the bore 244 may be implemented similarly to the bore 120 and is configured to slidably receive a stimulating probe such as the stimulating probe 170 therein.
- the outer surface 246 includes a channel 248 and a groove 250.
- the channel 248 may be implemented similarly to the channel 126 and is configured to slidably receive a stimulating probe therein.
- the groove 250 may be implemented similarly to the groove 200 and is configured to receive a portion of the second dilator therein as described below.
- the second dilator 232 includes an elongated body 252 including a sidewall 254, a bore 256, an outer surface 258, and a channel 260.
- the sidewall 254 has a thickness 262.
- the bore 256 may be implemented similarly to the bore 206 and is configured to matingly receive the first dilator 230 therein.
- the channel 260 is formed in sidewall 254 of the elongated body 252.
- the channel 260 is sized and configured to receive a standard or fixed size stimulating probe, such as the stimulating probe 170a, and has a diameter 264 which is larger than the thickness 262 of the sidewall 254 such that a bridge portion 266 of the sidewall 254 extends inwardly into the bore 256.
- the bridge portion 266 is configured to be matingly received in the groove 250 when the second dilator 232 is positioned over the first dilator 230.
- the diameter of the stimulating probe 170a may be about 3 mm
- the general thickness of the sidewall 254 of the elongated body 252 may in a range from about 1 mm to about 3 mm.
- the outer surface 258 includes a groove 268.
- the groove 268 may be implemented similarly to the groove 250 and is configured to receive a portion of the third dilator 234 therein as described below.
- the groove 268 may be offset from the channel 260 along the outer surface 258 at any desired angle or distance.
- the third dilator 234 may be implemented similarly to the second dilator 232 and includes an elongated body 270 including a sidewall 272, a bore 274, an outer surface 276, and a channel 278.
- the elongated body 270 may be implemented similarly to the elongated body 252 described above.
- the sidewall 272 has a width 280.
- the bore 274 may be implemented similarly to the bore 256 and is configured to matingly receive the second dilator 232 therein.
- the channel 278 is formed in sidewall 272 of the elongated body 270 and is sized and configured so as to receive a standard or fixed size stimulating probe, such as the stimulating probe 170a.
- the channel 278 has a diameter 282 which is larger than the width 280 of the sidewall 272 such that a bridge portion 284 of the sidewall 272 extends inwardly into the bore 274.
- the diameter of the stimulating probe 170a may be about 3 mm, while the general thickness of the sidewall 272 of the elongated body 270 may in a range from about 1 mm to about 3 mm.
- the bridge portion 284 is configured to be matingly received in the groove 268 when the second dilator 232 is matingly inserted into the bore 274.
- the channel 278 is offset from the channel 260.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Radiology & Medical Imaging (AREA)
- Optics & Photonics (AREA)
- Neurology (AREA)
- Surgical Instruments (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
Description
- The inventive concepts disclosed and claimed herein relate to systems for performing surgical procedures and, more particularly, but not by way of limitation, to systems and methods for accessing a surgical target site to perform surgical procedures.
- The present state of the art, when referencing a lateral surgical access approach, typically consists of using the following surgical instruments: neuromonitoring probe, dilators, and a retractor. Once an operative level is identified and an incision is created, dilators are used to create a surgical access site which is often followed by the use of a retractor or other specialized tools to create a surgical access corridor.
- During a lateral approach to a patient's spine, a psoas muscle, which is located on either side of the spine, is separated in order to access the spine and, in particular, an intervertebral disc space or one or more vertebral bodies within a patient's spinal column. It is desirable to avoid neural elements or nerves of the lumbar plexus that lie within the psoas muscle during such procedures. The anterior third of the psoas muscle is typically considered a safe zone for muscle separation.
- The neural elements or nerves of the psoas muscle may be mapped using a stimulating probe. In this manner, the most posterior neural or nerve-free area of the psoas muscle may be located and identified. The stimulating probe may then be inserted through the psoas muscle via the most posterior neural or nerve-free tissue area or through nearly any other region that is free of neural elements or nerves and toward the spine or into the intervertebral disc space in order to initiate safe tissue separation of the psoas muscle. Dilators are next placed over the probe to create and enlarge a surgical access site. Following the use of dilators, a retractor or other specialized tools are used to further enlarge the surgical access corridor.
- Concentric dilators separate the muscle radially, and as such, dilate tissue on all both sides of the stimulating probe in a uniform fashion. This in turn may impinge on neural elements or nerves located outside of the safe zone. Directional dilators have been suggested to overcome the problems associated with concentric dilators. While directional dilation systems are effective for avoiding known neural elements, they are limited in their ability to continuously monitor nerve proximity and to create a surgical access site of a desired shape while at the same time reducing the amount of tissue damage.
- US Patent Publication No.
US-2011/208226 discloses a dilation system including sequential directional dilators or a blunt stimulating dilator with at least one channel formed therein. A stimulating probe is inserted through the psoas muscle toward the patient's spine. The directional sequential dilators are inserted to dilate the tissue on any side of the stimulating probe. The dilators are rendered directional by having bores, by means of which they can be inserted over each other and over the probe, which are offset from their longitudinal axes. US Patent Publication No.US-2010/145391 discloses a set of surgical cannulas. - To assist those of ordinary skill in the relevant art in making and using the inventive concepts disclosed herein, reference is made to the appended drawings and schematics, which are not intended to be drawn to scale, and in which like reference numerals may refer to the same or similar elements for consistency. For purposes of clarity, not every component may be labeled in every drawing. Certain features and certain views of the figures may be shown exaggerated in scale or in schematic in the interest of clarity and conciseness. In the drawings:
-
FIG. 1 is a perspective view of an embodiment of a dilation system constructed in accordance with the inventive concepts disclosed herein. -
FIG. 2 is a top plan view of the dilation system ofFIG. 1 . -
FIG. 3 is a perspective view of a first dilator constructed in accordance with the inventive concepts disclosed herein. -
FIG. 4 is a top plan view of the first dilator ofFIG. 3 . -
FIG. 4A is a top plan view of another embodiment of a first dilator constructed in accordance with the inventive concepts disclosed herein. -
FIG. 5 is a perspective view of a second dilator constructed in accordance with the inventive concepts disclosed herein. -
FIG. 6 is a top plan view of the second dilator ofFIG. 5 . -
FIG. 7 is a perspective view of a third dilator constructed in accordance with the inventive concepts disclosed herein. -
FIG. 8 is a top plan view of the third dilator ofFIG. 7 . -
FIGS. 9A-9F illustrate a method of using the dilation system to dilate a surgical opening in a psoas muscle using the dilation system of the present invention. -
FIG. 10 is a top plan view of another dilation system, which does not fall within the scope of the invention as claimed. -
FIG. 11 is a top plan view of a first dilator of the dilation system ofFIG. 10 . -
FIG. 12 is a top plan view of a second dilator of the dilation system ofFIG. 10 . -
FIG. 13 is a top plan view of a third dilator of the dilation system ofFIG. 10 . -
FIG. 14 is a top plan view of another dilation system, which does not fall within the scope of the invention as claimed. -
FIG. 15 is a top plan view of a first dilator of the dilation system ofFIG. 14 . -
FIG. 16 is a top plan view of a second dilator of the dilation system ofFIG. 14 . -
FIG. 17 is a top plan view of a third dilator of the dilation system ofFIG. 14 . - In the following detailed description of embodiments of the inventive concepts, numerous specific details are set forth in order to provide a more thorough understanding of the inventive concepts. However, it will be apparent to one of ordinary skill in the art that the inventive concepts disclosed and claimed herein may be practiced without these specific details. In other instances, well-known features have not been described in detail to avoid unnecessarily complicating the instant disclosure.
- As used herein, the terms "comprises," "comprising," "includes," "including," "has," "having" or any other variation thereof, are intended to cover a non-exclusive inclusion. For example, a process, method, article, or apparatus that comprises a list of elements or steps is not necessarily limited to only those elements or steps and may include other elements, steps, or features not expressly listed or inherently present therein.
- Unless expressly stated to the contrary, "or" refers to an inclusive or and not to an exclusive or. For example, a condition A or B is satisfied by anyone of the following: A is true (or present) and B is false (or not present), A is false (or not present) and B is true (or present), and both A and B are true (or present).
- In addition, use of the "a" or "an" are employed to describe elements and components of the embodiments herein. This is done merely for convenience and to give a general sense of the inventive concepts. This description should be read to include one or at least one and the singular also includes the plural unless it is obvious that it is meant otherwise.
- Throughout this disclosure and the claims, the terms "about," "approximately," and "substantially" are intended to signify that the item being qualified is not limited to the exact value specified, but includes some slight variations or deviations therefrom, caused by measuring error, manufacturing tolerances, stress exerted on various parts, wear and tear, or combinations thereof, for example.
- The use of the term "at least one" will be understood to include one as well as any quantity more than one, including but not limited to each of, 2, 3, 4, 5, 10, 15, 20, 30, 40, 50, 100, and all integers therebetween. The term "at least one" may extend up to 100 or 1000 or more, depending on the term to which it is attached; in addition, the quantities of 100/1000 are not to be considered limiting, as higher limits may also produce satisfactory results. Singular terms shall include pluralities and plural terms shall include the singular unless indicated otherwise.
- The term "or combinations thereof as used herein refers to all permutations and/or combinations of the listed items preceding the term. For example, "A, B, C, or combinations thereof" is intended to include at least one of: A, B, C, AB, AC, BC, or ABC, and if order is important in a particular context, also BA, CA, CB, CBA, BCA, ACB, BAC, or CAB. Continuing with this example, expressly included are combinations that contain repeats of one or more item or term, such as BB, AAA, AAB, BBC, AAABCCCC, CBBAAA, CABABB, and so forth. The skilled artisan will understand that typically there is no limit on the number of items or terms in any combination, unless otherwise apparent from the context.
- Finally, as used herein any reference to "one embodiment" or "an embodiment" means that a particular element, feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment. The appearances of the phrase "in one embodiment" in various places in the specification are not necessarily referring to the same embodiment, although the inventive concepts disclosed herein are intended to encompass all combinations and permutations including one or more of the features of the embodiments described herein.
- As generally understood by one of ordinary skill in the art, dilation systems will be described in detail herein in connection with accessing the spine or performing a surgical procedure, but dilation systems according to the inventive concepts disclosed herein may find use in any desired orthopaedic or other surgical procedures in which a surgeon wishes to gain access to an internal cavity by cutting the skin and going through the body wall in order to keep the incision spread apart so that surgical instruments can be inserted in the internal cavity. For example, dilation systems according to the inventive concepts disclosed herein may be used for anteriorly or posteriorly accessing the spine, for accessing the thoracic or cervical region of the spine, or for accessing any other part, cavity, or organ of the body of a human being or an animal.
- Embodiments of dilation systems according to the inventive concepts disclosed herein may be used to gradually and atraumatically dilate a surgical opening by sequentially inserting two or more serial dilators into the surgical opening and rotating the dilators to enlarge the surgical opening. In some embodiments, the surgical opening may be enlarged by inserting a first dilator, rotating the first dilator, and inserting one or more second dilators over the first dilator, with each subsequent dilator being rotated to dilate the surgical opening. Further, in some embodiments dilations systems according to the inventive concepts disclosed herein may include reduced diameter dilators with standard or fixed-size stimulating probes.
- Referring to
FIGS. 1-2 , an embodiment of adilation system 100 is illustrated. Thedilation system 100 includes a first orinitial dilator 102, one or more second orintermediate dilators 104, and a third orfinal dilator 106 configured to be matingly coupled with one another around alongitudinal axis 108. It is to be understood that dilation systems according to the inventive concepts disclosed herein may include any desired number of dilators, such as two, three, four, or more dilators. Thedilation system 100 is configured to be used in combination with a monitoring K-wire or stimulating probe, suchstimulating probe 170 depicted inFIG. 9A , for transmitting an electrical pulse as described below. - Referring now to
FIGS. 3-4 , thefirst dilator 102 includes anelongated body 110 having alongitudinal axis 112, a proximal end 114 adistal end 116, and anouter surface 118. Theelongated body 110 may include abore 120. Theelongated body 110 has a substantially elliptical transverse cross-section and includes amajor axis 122 and aminor axis 124 which are substantially normal to one another (e.g., substantially perpendicular to one another). Theelongated body 110 has a first diameter (e.g., a transverse diameter) along themajor axis 122 and a second diameter (e.g., a conjugate diameter) along theminor axis 124, with the first diameter being greater than the second diameter. - The
outer surface 118 may include at least onechannel 126 formed therein and extending along theouter surface 118 from theproximal end 114 to thedistal end 116. Thechannel 126 is configured to slidably receive a stimulating probe, such as a stimulatingprobe 170a depicted inFIG. 9B ). Thechannel 126 may extend along theouter surface 118 such that thechannel 126 intersects themajor axis 122 of theelongated body 110 in some embodiments. It is to be understood that in some embodiments thechannel 126 may intersect theminor axis 124, may be tangential or positioned adjacent to themajor axis 122 or theminor axis 124, and/or may be positioned so as not to intersect either themajor axis 122 or theminor axis 124. Further, any number ofchannels 126 may be implemented with thefirst dilator 102 in some embodiments of the inventive concepts disclosed herein, such as two ormore channels 126. In some embodiments wheremultiple channels 126 are implemented, one or morefirst channels 126 may intersect themajor axis 122, and one or moresecond channels 126 may intersect theminor axis 124 as will be appreciated by persons of ordinary skill in the art having the benefit of the instant disclosure. - The
outer surface 118 may taper inwardly adjacent to thedistal end 116 so that thefirst dilator 102 is configured to minimize trauma to tissues when thedistal end 116 of thefirst dilator 102 is inserted into a tissue. In some embodiments, theouter surface 118 may include a plurality of graspingnotches 128 formed therein adjacent to theproximal end 114 of theelongated body 110. The graspingnotches 128 may be configured to allow a surgeon to grip the first dilator 102 (e.g., manually or via a suitable surgical tool or robotic arm) and to manipulate thefirst dilator 102 as will be described below. - Referring again to
FIG. 1 , theelongated body 110 of thefirst dilator 102 is sized relative to thesecond dilator 104 such that a portion of the elongated body 110 (e.g., theproximal end 114 and/or a portion of theouter surface 118 including the grasping notches 128) remains accessible when thedilation system 100 is assembled and used as will be described below. - The
bore 120 may extend through theelongated body 110 from theproximal end 114 to thedistal end 116 and is configured to slidably receive a stimulating probe or a guide wire therein. In the embodiment shown inFIGS. 3-4 , thebore 120 is substantially aligned with thelongitudinal axis 112. However, in some embodiments, thebore 120 may be laterally offset from thelongitudinal axis 112 or omitted. It is to be understood that while thebore 120 is shown as being substantially cylindrical in shape, thebore 120 may have any desired shape, size, and cross-section in some embodiments of the inventive concepts disclosed herein. For example, as shown inFIG. 4A , an embodiment of afirst dilator 102a may be implemented similarly to thefirst dilator 102 and may include abore 120a which is offset from thelongitudinal axis 112a. - The
first dilator 102 may be constructed of any desired material, such as stainless steel, surgical steel, titanium, metals, anodized aluminium, non-metals, polyether ether ketone (PEEK), polymers, resins, or combinations thereof, and may be constructed using any desired manufacturing technique, such as machining, casting, molding, or combinations thereof. In some embodiments, thefirst dilator 102 may be provided visual or haptic depth markings (e.g., along the outer surface 118) to indicate an appropriate insertion depth to a surgeon as will be appreciated by persons of ordinary skill in the art having the benefit of the instant disclosure. - Referring now to
FIGS. 5-6 , thesecond dilator 104 may be implemented similarly to thefirst dilator 102 and includes anelongated body 130 having alongitudinal axis 132, aproximal end 134, adistal end 136, anouter surface 138 extending between theproximal end 134 and thedistal end 136, and abore 140 extending from theproximal end 134 to thedistal end 136. Theelongated body 130 has a substantially elliptical transverse cross-section and includes a major axis 142 and a minor axis 144 being substantially normal (e.g., substantially perpendicular) to the major axis 142. Theelongated body 130 has a first diameter (e.g., a transverse diameter) along the major axis 142 and a second diameter (e.g., a conjugate diameter) along the minor axis 144, with the first diameter being greater than the second diameter. - The
bore 140 is sized, shaped, and configured to matingly and slidably receive thefirst dilator 102 therein so that the major axis 142 of thesecond dilator 104 is aligned with theminor axis 124 of thefirst dilator 102 and the minor axis 144 of thesecond dilator 104 is aligned with themajor axis 122 of thefirst dilator 102. - The
outer surface 138 has at least onechannel 146 for receiving a stimulating probe, thechannel 146 extending from theproximal end 134 to thedistal end 136 and intersecting the major axis 142 of theelongated body 130. It is to be understood that in some embodiments, thechannel 146 may intersect the minor axis 144, may be tangential or positioned adjacent to the major axis 142 or the minor axis 144, and/or may be positioned so as not to intersect either the major axis 142 or the minor axis 144. Further, any number ofchannels 146 may be implemented with thesecond dilator 104 in some embodiments of the inventive concepts disclosed herein, such as two ormore channels 146. In some embodiments wheremultiple channels 146 are implemented, one ormore channel 146 may intersect the major axis 142, and one ormore channel 146 may intersect the minor axis 144 as will be appreciated by persons of ordinary skill in the art having the benefit of the instant disclosure. - The
outer surface 138 may taper adjacent to thedistal end 136 so as to facilitate insertion into tissue. The general shape of thefirst dilator 102 is atraumatic. In some embodiments, theouter surface 138 may include a plurality of graspingnotches 148 formed therein adjacent to theproximal end 134 of theelongated body 130. The graspingnotches 148 may be configured to allow a surgeon to grip the second dilator 104 (e.g., manually or via a suitable surgical tool) and to manipulate thesecond dilator 104 as will be described below. - Referring again to
FIG. 1 , theelongated body 130 of thesecond dilator 104 is sized relative to thethird dilator 106, such that a portion of the elongated body 130 (e.g., theproximal end 134 and/or a portion of theouter surface 138 including the grasping notches 148) remains accessible when thedilation system 100 is assembled and used as will be described below. - As will be appreciated by persons of ordinary skill in the art having the benefit of the instant disclosure, any desired number of second or
intermediate dilators 104 may be implemented with thedilation system 100, such as one, two, three, or more of thesecond dilators 104. For example, where multiplesecond dilators 104 are implemented with an embodiment of thedilation system 100, each successivesecond dilator 104 may have abore 140 configured to matingly (e.g., slidably) receive a precedingsecond dilator 104 therein such that the major axis 142 of one of the precedingsecond dilator 104 is substantially aligned with a minor axis 144 of the successivesecond dilator 104 and the minor axis 144 of the precedingsecond dilator 104 is substantially aligned with the major axis 142 of the successivesecond dilator 104. - Referring now to
FIGS. 7-8 , thethird dilator 106 may be implemented similarly to thefirst dilator 102 and includes anelongated body 150 havinglongitudinal axis 152, aproximal end 154, adistal end 156, anouter surface 158 extending between theproximal end 154 and thedistal end 156, and abore 160 extending from theproximal end 154 to thedistal end 156. Theelongated body 150 is illustrated as having a substantially circular transverse cross-section and is configured so as to allow thethird dilator 106 to interface with a retractor, such as a multi-blade retractor in some embodiments. - The
outer surface 158 may include at least onechannel 166 for receiving a stimulating probe therein. Thechannel 166 may extend from theproximal end 154 to thedistal end 156 and may be positioned so as to intersect the minor axis 144 of theelongated body 130 when thesecond dilator 104 is matingly received in thethird dilator 106. It is to be understood that in some embodiment thechannel 166 may be tangential or positioned adjacent to the major axis 142 and/or may be spaced a distance from the major axis 142. Further, any number ofchannels 166 may be implemented with thethird dilator 106 in some embodiments of the inventive concepts disclosed herein, such as two ormore channels 166. - The
outer surface 158 may taper adjacent to thedistal end 156 so as to facilitate insertion into tissue. The general shape of thesecond dilator 104 is atraumatic. In some embodiments, theouter surface 158 may include a plurality of grasping notches 159 formed therein adjacent to theproximal end 154 of theelongated body 150. The grasping notches 159 may be configured to allow a surgeon to grip the third dilator 106 (e.g., manually or via a suitable surgical tool) and to manipulate thethird dilator 106 as described below. - The
bore 160 has a substantially elliptical transverse cross-section and includes amajor axis 162 and aminor axis 164, which may be substantially normal to one another. Thebore 160 has a first diameter (e.g., a transverse diameter) along themajor axis 162 and a second diameter (e.g., a conjugate diameter) along theminor axis 164, with the first diameter being greater than the second diameter. Thebore 160 is configured to matingly and slidably receive thesecond dilator 104 therein such that the major axis 142 of theelongated body 130 is aligned with themajor axis 162 of thebore 160 and such that the minor axis 144 of theelongated body 130 is aligned with theminor axis 164 of thebore 160. - As will be appreciated by persons of ordinary skill in the art having the benefit of the instant disclosure, in some embodiments the
third dilator 106 may be omitted, while in some embodiments multiplethird dilators 106 may be implemented, with each successivethird dilator 106 having abore 160 configured to matingly receive a precedingthird dilator 106 therein. - Referring now to
FIGS. 9A-9F , an exemplary embodiment of a method of using thedilation system 100 to access a lumbar region of a spine via a lateral approach will be described herein. The method does not fall within the scope of the invention as claimed. A similar or the same method may be used with thedilation system 100 in other parts of a patient's body. - Using a stimulating
probe 170 and an electromyograph (EMG) (not shown) in a manner similar to that described inU.S. Publication No. 2011/0208226 , a surgeon may map a safe zone (e.g., a zone generally free of neural elements or nerves) on a tissue of interest (e.g., psoas muscle). For example, on a human psoas muscle, the anterior third of the psoas muscle is generally considered a safe zone. Once a safe zone is established, anatomical placement may be confirmed via intra-operative fluoroscopy. - With a safe zone established, anatomical placement may be confirmed via intra-operative fluoroscopy. The surgeon inserts the stimulating
probe 170 through the psoas muscle toward the patient's spine, as shown inFIG. 9A . If the surgery is being performed on the intervertebral disc space, the distal end of the stimulatingprobe 170 may be inserted into the annulus of the desired intervertebral disc space or may be positioned so that a tip of the stimulatingprobe 170 is proximate to the patient'sspine 174. The stimulatingprobe 170 may be inserted via the most posterior portion of the safe zone in some embodiments. - As shown in
FIG. 9B , the surgeon may insert or slide thefirst dilator 102 over the stimulating probe 170 (e.g., such that the stimulatingprobe 170 is slidably received in thebore 120 of the first dilator 102) and may insert thedistal end 116 and/or a portion of theelongated body 110 of thefirst dilator 102 through thepsoas muscle 172 and toward the patient'sspine 174. In some procedures, thefirst dilator 102 may be inserted through the psoas muscle without the use of a stimulating probe or guide wire. To minimize trauma to thepsoas muscle 172 from the insertion of thefirst dilator 102 thefirst dilator 102 is inserted into thepsoas muscle 172 such that themajor axis 122 is oriented substantially parallel to the prevalent direction or orientation ofpsoas muscle fibers 176 adjacent to the insertion site and theminor axis 124 is oriented substantially perpendicular to the prevalent direction or orientation ofpsoas muscle fibers 176 adjacent to the insertion site. With thefirst dilator 102 inserted through the psoas muscle, an additional or secondarystimulating probe 170a may be inserted into thechannel 126 to allow the surgeon determine the proximity of neural elements or nerves. - As shown in
FIG. 9C , the surgeon may then rotate thefirst dilator 102 about thelongitudinal axis 112 about 90° or about 270° (e.g., clockwise or counter clockwise) such that themajor axis 122 is substantially perpendicular to the prevalent direction or orientation ofpsoas muscle fibers 176 adjacent to the insertion site and such that theminor axis 124 is substantially parallel to the prevalent direction or orientation ofpsoas muscle fibers 176 adjacent to the insertion site The stimulatingprobe 170a may be utilized before, during, and/or during rotating thefirst dilator 102 to transmit one or more electrical pulses via an EMG into the stimulating probe to determine the proximity of neural elements or nerves. For example, thefirst dilator 102 may be rotated so as to complete one or more rotations about thelongitudinal axis 112 to enable the surgeon to locate a safe zone and/or determine the proximity of neural elements or nerves via the stimulatingprobe 170a. The insertion site is dilated or enlarged by the rotation of thefirst dilator 102 as a result of themajor axis 122 of thefirst dilator 102 being greater than theminor axis 124 thereof. The stimulatingprobe 170a may be removed from thefirst dilator 102 after thefirst dilator 102 is rotated as described above. - As shown in
FIG. 9D , the surgeon can insert thesecond dilator 104 over thefirst dilator 102 and towards the patient'sspine 174 by receiving thefirst dilator 102 in thebore 140 of thesecond dilator 104 in a way that the minor axis 144 of thesecond dilator 104 is aligned with themajor axis 122 of thefirst dilator 102 the major axis 142 of thesecond dilator 104 is aligned with theminor axis 124 of thefirst dilator 102. This arrangement of thesecond dilator 104 relative to thefirst dilator 102 results in thedistal end 136 of thesecond dilator 104 being initially inserted into thepsoas muscle 172 so that the minor axis 144 of thesecond dilator 104 is oriented substantially perpendicular to the prevalent direction or orientation ofpsoas muscle fibers 176 adjacent to the insertion site and the major axis 142 is substantially parallel to the prevalent direction or orientation ofpsoas muscle fibers 176. With thesecond dilator 104 inserted through thepsoas muscle 172, the stimulatingprobe 170a may be inserted into thechannel 146 to allow the surgeon to determine the proximity of neural elements or nerves. - As shown in
FIG. 9E , the surgeon may rotate thesecond dilator 104 about thelongitudinal axis 132 about 90° or about 270° (e.g., clockwise or counter clockwise) such that the major axis 142 is substantially perpendicular to the prevalent direction or orientation ofpsoas muscle fibers 176 adjacent to the insertion site and such that the minor axis 144 is substantially parallel to the prevalent direction or orientation ofpsoas muscle fibers 176 adjacent to the insertion site. The stimulatingprobe 170a may be utilized before, during, and/or during rotating thesecond dilator 104 to transmit one or more electrical pulses via an EMG into the stimulatingprobe 170a to determine the proximity of neural elements or nerves. For example, thesecond dilator 104 may be rotated so as to complete one or more rotations about thelongitudinal axis 132 to enable the surgeon to determine the proximity of neural elements or nerves via the stimulatingprobe 170a. The stimulatingprobe 170a may be removed after thesecond dilator 104 is rotated as described above. - The
first dilator 102 is matingly received in thebore 140 of thesecond dilator 104 such that thesecond dilator 104 and thefirst dilator 102 move as a unit when thesecond dilator 104 is rotated. The insertion site is further dilated or enlarged by the rotation of thesecond dilator 104 as a result of the major axis 142 of thesecond dilator 104 being larger than the minor axis 144 of thesecond dilator 104. - The surgeon can insert one or more second or
intermediate dilators 104 in a similar manner and rotating each successivesecond dilator 104 about 90° or about 270° (e.g., clockwise or counter clockwise) after insertion. - As shown in
FIG. 9F , the surgeon can insert the third orfinal dilator 106 over thesecond dilator 104, for example, by slidably receiving thesecond dilator 104 in thebore 160 of thethird dilator 106 such that the major axis 142 of thesecond dilator 104 is aligned with themajor axis 162 of thebore 160 and the minor axis 144 is aligned with theminor axis 164 of thebore 160. Thesecond dilator 104 is matingly received in thebore 160 of thethird dilator 106 such that thethird dilator 106 and thesecond dilator 104 move as a unit when thethird dilator 106 is rotated. With thethird dilator 106 inserted through thepsoas muscle 172, the stimulatingprobe 170a may be inserted into thechannel 166 to allow the surgeon to determine the proximity of neural elements or nerves by transmitting one or more electrical pulses via an EMG into the stimulating probe. For example, the surgeon may rotate thethird dilator 106 between about 0° and about 360° (clockwise or counter clockwise) about thelongitudinal axis 152 to enable the surgeon to determine the proximity of neural elements or nerves by transmitting one or more electrical pulses via an EMG into the stimulating probe 170d. - The
third dilator 106 may interface with a retractor (not shown) that can be inserted over thethird dilator 106 to subsequently retract the tissue and to permit removal of thedilation system 100 and the stimulatingprobes - As will be appreciated by persons of ordinary skill in the art, in some instances an external diameter of the dilators of dilation systems dictates the size of retractors that can be used with the particular dilation system. When the retractors have a relatively small diameter, generally smaller dilators are used to dilate the muscle prior to inserting the retractor. However, smaller diameter dilators may not have a sufficient thickness to accommodate a probe channel therein. This problem is especially relevant to the diameters of second and subsequent sequential dilators that are inserted over one another in a sequence. To address this issue, the first dilator may have an overall diameter configured to be as small as possible while still allowing the first dilator to accommodate a stimulating probe bore or channel therein. The second and subsequent dilators may be modified such that a portion of the respective stimulating probe channels extend into a bore for receiving the preceding dilator, thus resulting in a reduced overall diameter of each dilator and of the dilation system as a whole, while using a standard or fixed size stimulating probe.
- Referring now to
FIGS. 10-13 , shown therein is an example of anotherdilation system 100a, which does not fall within the scope of the invention as claimed. Thedilation system 100a includes a first orinitial dilator 180, a second orintermediate dilator 182, and a third orfinal dilator 184. Thedilation system 100a may be configured to be used in combination with a monitoring K-wire or stimulating probe for transmitting an electrical pulse as described above. - As shown in
FIG. 11 , thefirst dilator 180 includes anelongated body 188 having alongitudinal axis 190, abore 192, and anouter surface 194. Theelongated body 188 can be implemented similarly to theelongated body 110. Thebore 192 may be implemented similarly to thebore 120 and is sized and configured to slidably receive a stimulating probe, such as the stimulatingprobe 170. In one embodiment, thebore 192 may be omitted from theelongated body 110. - The
outer surface 194 has a substantially circular transverse cross-section but includes a channel 196, a keyingslot 198, and a groove 200. Theouter surface 194 may taper at a distal end of theelongated body 188 to facilitate insertion into tissue. The general shape of thefirst dilator 180 is atraumatic. - The channel 196 may be implemented similarly to the
channel 126 and is configured to slidably receive a stimulating probe therein, such as the stimulatingprobe 170a. The keyingslot 198 is configured to receive a keying pin therein so as to key the orientations of thefirst dilator 180 and thesecond dilator 182 relative to one another. It is to be understood that the keyingslot 198 may have any desired shape, size, or cross-section and may be located adjacent to a proximal end of theelongated body 188 or may extend partially or substantially completely along theouter surface 194 of theelongated body 188 in some embodiments so as to not cause trauma to tissues or interfere with dilating a surgical opening during use of thefirst dilator 180. - The groove 200 is formed in the
outer surface 194 and extends along theelongated body 188 such that the groove 200 may be aligned with a corresponding groove formed in thesecond dilator 182 as described below so as to form a combined lateral bore 202 (FIG. 10 ) for receiving a stimulating probe (e.g., the stimulatingprobe 170a). In some embodiments, the groove 200 is formed in theouter surface 194 so that the groove 200 is offset from the channel 196 at any desired distance or angle. In the embodiment shown inFIG. 11 , the groove 200 is diametrically opposed to the channel 196 along theouter surface 194, however, in some embodiments the groove 200 may be adjacent to, tangential to, or positioned at any desired location along theouter surface 194 relative to the channel 196. - Referring now to
FIG. 12 , thesecond dilator 182 includes anelongated body 204 having a bore 206, and anouter surface 208. The bore 206 includes agroove 210 and akeying pin 212 formed therein and is sized, shaped, and configured to matingly and slidably receive thefirst dilator 180 therein so that thegroove 210 aligns with the groove 200 of thefirst dilator 180 when thefirst dilator 180 is matingly received in the bore 206 such that thegroove 210 and the groove 200 cooperate with one another to define the lateral bore 202 (FIG. 10 ) for receiving a stimulating probe, such as the stimulatingprobe 170a. As will be appreciated by persons of ordinary skill in the art having the benefit of the instant disclosure, thegrooves 200 and 210 are configured so that when a stimulating probe, such as the stimulatingprobe 170a is inserted into thelateral bore 202, a portion of the stimulatingprobe 170 is received in the groove 200 and a portion of the stimulatingprobe 170 is received in thegroove 210. By way of example, the diameter of the stimulatingprobe 170a may be about 3 mm, while the general thickness of the elongated body 206 may in a range from about 1 mm to about 3 mm. - The keying
pin 212 is configured to be matingly received in thekeying slot 198 such that thefirst dilator 180 is matingly received in thesecond dilator 182 so that thegroove 210 aligns with the groove 200 to form thelateral bore 202. - The
outer surface 208 includes agroove 214 and akeying slot 216. Theouter surface 208 may be tapered at a distal end of theelongated body 204 to facilitate insertion into tissue. The general shape of thesecond dilator 182 is atraumatic. - The
groove 214 may be implemented similarly to the groove 200 and extends along theelongated body 204, such that thegroove 214 may be aligned with a corresponding groove formed in thethird dilator 184 as described below so as to form a lateral bore 218 (FIG. 10 ) for receiving a stimulating probe therein. Thegroove 214 may be formed at any desired location in theouter surface 208. In some examples, thegroove 214 may be positioned along theouter surface 208 so that thegroove 214 aligns with the channel 196 when thefirst dilator 180 is matingly received by thesecond dilator 182. - The keying
slot 216 may be implemented similarly to thekeying slot 198 and is configured re receive a keying pin therein. The keyingslot 216 may be positioned at any desired location and may be offset from thegroove 214, the keyingpin 212, and thegroove 210 in some examples. - Referring now to
FIG. 13 , thethird dilator 184 may be implemented similarly to thethird dilator 106 and includes anelongated body 220 having a bore 222 and anouter surface 224. The bore 222 may be implemented similarly to the bore 206 and includes agroove 226 and a keying pin 228. The bore 222 is configured to matingly receive thesecond dilator 182 therein so that thegroove 226 aligns with thegroove 214 of thesecond dilator 182 when thesecond dilator 182 is matingly received in the bore 222 such that thegroove 226 and thegroove 214 cooperate with one another to define the lateral bore 218 (FIG. 10 ) for receiving a stimulating probe such as the stimulatingprobe 170 therein. By way of example, the diameter of the stimulatingprobe 170a may be about 3 mm, while the general thickness of theelongated body 220 may in a range from about 1 mm to about 3 mm. - Further, the keying pin 228 is matingly received in the
keying slot 216 of thesecond dilator 182 so as to align thesecond dilator 182 and thethird dilator 184 relative to one another as described above. - The
outer surface 224 is configured so that thethird dilator 184 interfaces with a retractor to subsequently retract the tissue and to permit removal of thedilation system 100a and the stimulating probes. - As will be appreciated by persons of ordinary skill in the art having the benefit of the instant disclosure, the
dilation system 100a may be implemented with any number of dilators for example two, three, four, or more. - Referring now to
FIGS. 14-17 , shown therein is another example of adilation system 100b, which does not fall within the scope of the invention as claimed. Thedilation system 100b includes a first orinitial dilator 230, a second orintermediate dilator 232, and a third orfinal dilator 234 configured to be matingly coupled with one another. Thedilation system 100b is configured to be used in combination with a monitoring K-wire or stimulating probe, such as the stimulatingprobe 170, for transmitting an electrical pulse. - Referring now to
FIG. 15 , thefirst dilator 230 includes anelongated body 240 having alongitudinal axis 242, a bore 244, and anouter surface 246. The bore 244 may be implemented similarly to thebore 120 and is configured to slidably receive a stimulating probe such as the stimulatingprobe 170 therein. - The
outer surface 246 includes achannel 248 and agroove 250. Thechannel 248 may be implemented similarly to thechannel 126 and is configured to slidably receive a stimulating probe therein. Thegroove 250 may be implemented similarly to the groove 200 and is configured to receive a portion of the second dilator therein as described below. - Referring now to
FIG. 16 , thesecond dilator 232 includes an elongated body 252 including a sidewall 254, abore 256, an outer surface 258, and a channel 260. The sidewall 254 has athickness 262. Thebore 256 may be implemented similarly to the bore 206 and is configured to matingly receive thefirst dilator 230 therein. - The channel 260 is formed in sidewall 254 of the elongated body 252. In some embodiments, the channel 260 is sized and configured to receive a standard or fixed size stimulating probe, such as the stimulating
probe 170a, and has adiameter 264 which is larger than thethickness 262 of the sidewall 254 such that abridge portion 266 of the sidewall 254 extends inwardly into thebore 256. Thebridge portion 266 is configured to be matingly received in thegroove 250 when thesecond dilator 232 is positioned over thefirst dilator 230. By way of example, the diameter of the stimulatingprobe 170a may be about 3 mm, while the general thickness of the sidewall 254 of the elongated body 252 may in a range from about 1 mm to about 3 mm. - The outer surface 258 includes a
groove 268. Thegroove 268 may be implemented similarly to thegroove 250 and is configured to receive a portion of thethird dilator 234 therein as described below. As will be appreciated by persons of ordinary skill in the art having the benefit of the instant disclosure, in some embodiments thegroove 268 may be offset from the channel 260 along the outer surface 258 at any desired angle or distance. - Referring now to
FIG. 17 , thethird dilator 234 may be implemented similarly to thesecond dilator 232 and includes anelongated body 270 including asidewall 272, abore 274, anouter surface 276, and achannel 278. Theelongated body 270 may be implemented similarly to the elongated body 252 described above. Thesidewall 272 has awidth 280. Thebore 274 may be implemented similarly to thebore 256 and is configured to matingly receive thesecond dilator 232 therein. Thechannel 278 is formed insidewall 272 of theelongated body 270 and is sized and configured so as to receive a standard or fixed size stimulating probe, such as the stimulatingprobe 170a. Thechannel 278 has adiameter 282 which is larger than thewidth 280 of thesidewall 272 such that abridge portion 284 of thesidewall 272 extends inwardly into thebore 274. By way of example, the diameter of the stimulatingprobe 170a may be about 3 mm, while the general thickness of thesidewall 272 of theelongated body 270 may in a range from about 1 mm to about 3 mm. Thebridge portion 284 is configured to be matingly received in thegroove 268 when thesecond dilator 232 is matingly inserted into thebore 274. As will be appreciated by persons of ordinary skill in the art having the benefit of the instant disclosure, due to thegroove 268 being offset from the channel 260 as described above, thechannel 278 is offset from the channel 260. - From the above description, it is clear that the inventive concepts disclosed and claimed herein are well adapted to carry out the objects and to attain the advantages mentioned herein, as well as those inherent in the invention. While exemplary embodiments of the inventive concepts have been described for purposes of this disclosure, it will be understood that numerous changes may be made which will readily suggest themselves to those skilled in the art and which are accomplished within the inventive concepts disclosed and claimed herein.
Claims (9)
- A dilation system (100), comprising:a first dilator (102) including an elongated body (110) having longitudinal axis (112), a proximal end (114), a distal end (116), and an outer surface (118) extending between the proximal end and the distal end, the first dilator having a major axis (122) and a minor axis (124), the minor axis being substantially normal to the major axis, said elongated body having a cross-section having a first diameter along the major axis and a second diameter along the minor axis with the first diameter being greater than the second diameter; anda second dilator (104) including an elongated body (130) having longitudinal axis (132), a proximal end (134), a distal end (136), an outer surface (138) extending between the proximal end and the distal end, and a bore (140) extending from the proximal end to the distal end, the second dilator having a major axis (142) and a minor axis (144), the minor axis of the second dilator being substantially normal to the major axis of the second dilator, said elongated body of said second dilator having a cross-section having a first diameter along the major axis of the second dilator and a second diameter along the minor axis of the second dilator with the first diameter of the second dilator being greater than the second diameter of the second dilator, characterized in that, the bore of the second dilator is configured to matingly receive the first dilator in such a way that the major axis of the second dilator is aligned with the minor axis of the first dilator and the minor axis of the second dilator is aligned with the major axis of the first dilator.
- The dilation system of claim 1, wherein the elongated body (110) of the first dilator has a bore (120) extending from the proximal end to the distal end, and wherein the bore of the first dilator is aligned with the longitudinal axis (112) of the first dilator.
- The dilation system of claim 1, wherein the elongated body (110) of the first dilator has a bore (120) extending from the proximal end to the distal end, and wherein the bore of the first dilator is offset relative to the longitudinal axis (112) of the first dilator.
- The dilation system of claim 2, wherein the bore (140) of the second dilator is aligned with the longitudinal axis (132) of the second dilator.
- The dilation system of claim 1, wherein the elongated body (110) of the first dilator has at least one channel (126) for receiving a stimulating probe (170a), the channel extending from the proximal end to the distal end and intersecting the major axis (122) of the first dilator.
- The dilation system of claim 5. wherein the elongated body (130) of the second dilator has at least one channel (146) for receiving a stimulating probe (170a), the channel extending from the proximal end to the distal end and intersecting the major axis (142) of the second dilator.
- The dilation system of claim 1, wherein the elongated body (130) of the second dilator has at least one channel (146) for receiving a stimulating probe (170a), the channel extending from the proximal end to the distal end and intersecting the major axis (142) of the second dilator.
- The dilation system of claim 1 further comprising:a third dilator (106) including an elongated body (150) having longitudinal axis (152), a proximal end (154), a distal end (156), an outer surface (158) extending between the proximal end and the distal end, and a bore (160) extending from the proximal end to the distal end, the third dilator having a substantially circular transverse cross section, the bore of the third dilator configured to matingly receive the second dilator (104).
- The dilation system of claim 8, wherein the elongated body (150) of the third dilator has at least one channel (166) for receiving a stimulating probe (170a), the channel extending from the proximal end to the distal end.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/147,345 US9339263B2 (en) | 2014-01-03 | 2014-01-03 | Dilation system and method |
PCT/US2014/072318 WO2015103066A1 (en) | 2014-01-03 | 2014-12-24 | Dilation system and method |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3089684A1 EP3089684A1 (en) | 2016-11-09 |
EP3089684B1 true EP3089684B1 (en) | 2018-03-07 |
Family
ID=52392232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP14828421.9A Active EP3089684B1 (en) | 2014-01-03 | 2014-12-24 | Dilation system |
Country Status (5)
Country | Link |
---|---|
US (1) | US9339263B2 (en) |
EP (1) | EP3089684B1 (en) |
JP (1) | JP6486945B2 (en) |
AU (1) | AU2014374049B2 (en) |
WO (1) | WO2015103066A1 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8834527B2 (en) * | 2006-06-16 | 2014-09-16 | Alphatec Spine, Inc. | Systems and methods for manipulating and/or installing a pedicle screw |
CA2725811A1 (en) | 2008-06-06 | 2009-12-10 | Providence Medical Technology, Inc. | Facet joint implants and delivery tools |
US9717403B2 (en) | 2008-12-05 | 2017-08-01 | Jeffrey B. Kleiner | Method and apparatus for performing retro peritoneal dissection |
US8992558B2 (en) | 2008-12-18 | 2015-03-31 | Osteomed, Llc | Lateral access system for the lumbar spine |
CN107072697A (en) | 2014-05-27 | 2017-08-18 | 普罗维登斯医疗技术公司 | Lateral mass fixation implant |
US10201375B2 (en) * | 2014-05-28 | 2019-02-12 | Providence Medical Technology, Inc. | Lateral mass fixation system |
US20160158501A1 (en) * | 2014-12-04 | 2016-06-09 | David Farris | Percutaneous scalpel and tissue dilator |
US10702305B2 (en) * | 2016-03-23 | 2020-07-07 | Coopersurgical, Inc. | Operative cannulas and related methods |
EP3457950B8 (en) * | 2016-05-20 | 2023-07-26 | Choice Spine, LLC | Access instruments to extend a surgical working channel |
EP3503814B1 (en) | 2016-08-23 | 2024-07-10 | Stryker European Operations Holdings LLC | Instrumentation for the implantation of spinal implants |
EP3624708A1 (en) | 2017-05-19 | 2020-03-25 | Providence Medical Technology, Inc. | Spinal fixation access and delivery system |
EP3443912B1 (en) * | 2017-08-17 | 2022-08-24 | Stryker European Operations Holdings LLC | Expanders for rod retraction |
US11191532B2 (en) | 2018-03-30 | 2021-12-07 | Stryker European Operations Holdings Llc | Lateral access retractor and core insertion |
US12144513B2 (en) | 2018-09-21 | 2024-11-19 | Providence Medical Technology, Inc. | Vertebral joint access and decortication devices and methods of using |
US11413029B2 (en) | 2018-10-24 | 2022-08-16 | Stryker European Operations Holdings Llc | Anterior to psoas instrumentation |
US12016543B2 (en) * | 2019-02-12 | 2024-06-25 | Edward Rustamzadeh | Lateral retractor system for minimizing muscle damage in spinal surgery |
US11246582B2 (en) * | 2019-02-12 | 2022-02-15 | Edward Rustamzadeh | Dual-motion rotation and retraction system for minimizing muscle damage in spinal surgery |
EP3808282A3 (en) * | 2019-09-01 | 2021-06-30 | Bb Surgical Devices, S.L. | Universal surgical access system |
US11564674B2 (en) | 2019-11-27 | 2023-01-31 | K2M, Inc. | Lateral access system and method of use |
US11617663B2 (en) * | 2020-10-15 | 2023-04-04 | Spineology Inc. | Surgical access system and method |
KR102486623B1 (en) * | 2020-10-15 | 2023-01-09 | 가톨릭대학교 산학협력단 | Non-circular dilator unit for minimally invasive spinal surgery |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5782807A (en) * | 1995-10-20 | 1998-07-21 | Tfx Medical Incorporated | Releasably locking introducer devices |
US5776110A (en) * | 1996-01-26 | 1998-07-07 | United States Surgical Corporation | Thoracic port |
US5976146A (en) * | 1997-07-11 | 1999-11-02 | Olympus Optical Co., Ltd. | Surgical operation system and method of securing working space for surgical operation in body |
US6895283B2 (en) * | 2000-08-10 | 2005-05-17 | Advanced Neuromodulation Systems, Inc. | Stimulation/sensing lead adapted for percutaneous insertion |
WO2003026482A2 (en) * | 2001-09-25 | 2003-04-03 | Nuvasive, Inc. | System and methods for performing surgical procedures and assessments |
US7008431B2 (en) * | 2001-10-30 | 2006-03-07 | Depuy Spine, Inc. | Configured and sized cannula |
US7824410B2 (en) * | 2001-10-30 | 2010-11-02 | Depuy Spine, Inc. | Instruments and methods for minimally invasive spine surgery |
US7074226B2 (en) * | 2002-09-19 | 2006-07-11 | Sdgi Holdings, Inc. | Oval dilator and retractor set and method |
US8340779B2 (en) * | 2003-08-29 | 2012-12-25 | Medtronic, Inc. | Percutaneous flat lead introducer |
US7998104B2 (en) * | 2003-11-21 | 2011-08-16 | Silk Road Medical, Inc. | Method and apparatus for treating a carotid artery |
US7762951B2 (en) * | 2004-06-25 | 2010-07-27 | Medtronic, Inc. | Vein harvesting system including dilator shaft and removable retractor housing |
US20060089536A1 (en) * | 2004-10-26 | 2006-04-27 | U.S. Spinal Technologies, Llc | Expandable surgical retractor system for minimal access surgery |
JP5166239B2 (en) * | 2005-03-30 | 2013-03-21 | アクセス サイエンティフィック、インク. | Vascular access |
US8075581B2 (en) * | 2005-05-24 | 2011-12-13 | Lanx, Inc. | Muscle saving device and method |
US9801637B2 (en) * | 2006-03-13 | 2017-10-31 | Pneumrx, Inc. | Genetically-associated chronic obstructive pulmonary disease treatment |
US8888800B2 (en) * | 2006-03-13 | 2014-11-18 | Pneumrx, Inc. | Lung volume reduction devices, methods, and systems |
JP2009537283A (en) * | 2006-05-19 | 2009-10-29 | アヴァンティス メディカル システムズ インコーポレイテッド | Apparatus and method for reducing the effects of video artifacts |
US9387009B2 (en) * | 2007-10-05 | 2016-07-12 | DePuy Synthes Products, Inc. | Dilation system and method of using the same |
US8932207B2 (en) * | 2008-07-10 | 2015-01-13 | Covidien Lp | Integrated multi-functional endoscopic tool |
US8634932B1 (en) * | 2008-07-21 | 2014-01-21 | Greatbatch Ltd. | Minimally invasive methods for implanting a sacral stimulation lead |
ES2363402B1 (en) * | 2008-08-01 | 2012-06-19 | Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud En Sevilla (Fundac. Sevilla) | PROGRESSIVE SURGICAL DISTRACTOR FOR ATRAUMATIC ACCESS. |
US8876851B1 (en) * | 2008-10-15 | 2014-11-04 | Nuvasive, Inc. | Systems and methods for performing spinal fusion surgery |
US20100114147A1 (en) * | 2008-10-30 | 2010-05-06 | The University Of Toledo | Directional soft tissue dilator and docking pin with integrated light source for optimization of retractor placement in minimally invasive spine surgery |
US8366748B2 (en) * | 2008-12-05 | 2013-02-05 | Kleiner Jeffrey | Apparatus and method of spinal implant and fusion |
US20100217090A1 (en) * | 2009-02-26 | 2010-08-26 | Heiges Bradley A | Retractor and mounting pad |
US8998803B2 (en) * | 2009-04-30 | 2015-04-07 | Boston Scientific Scimed, Inc. | Dissection and retraction device for vaginal sacral colpopexy |
US8608652B2 (en) * | 2009-11-05 | 2013-12-17 | Ethicon Endo-Surgery, Inc. | Vaginal entry surgical devices, kit, system, and method |
US20110118603A1 (en) * | 2009-11-19 | 2011-05-19 | Sean Suh | Spinous Navigation System and Associated Methods |
US7879009B1 (en) * | 2010-01-29 | 2011-02-01 | Warsaw Orthopedic, Inc. | Variable opening delivery system for intervertebral disc therapies |
US20110196206A1 (en) * | 2010-02-05 | 2011-08-11 | Tyco Healthcare Group Lp | Port fixation with varying thread diameter |
TWI409048B (en) * | 2010-06-11 | 2013-09-21 | Endoscopy apparatus having high degree of motion freedom and operating method thereof | |
US8603036B2 (en) * | 2010-07-01 | 2013-12-10 | Cook Medical Technologies Llc | Vascular introducer and method of using same |
US20170112480A9 (en) * | 2010-12-17 | 2017-04-27 | Boston Scientific Scimed, Inc. | Expandable device sheath for vascular closure plug deployment |
US8394129B2 (en) * | 2011-03-10 | 2013-03-12 | Interventional Spine, Inc. | Method and apparatus for minimally invasive insertion of intervertebral implants |
US8518087B2 (en) * | 2011-03-10 | 2013-08-27 | Interventional Spine, Inc. | Method and apparatus for minimally invasive insertion of intervertebral implants |
US20130345510A1 (en) * | 2011-05-10 | 2013-12-26 | Ron Hadani | Method and endoscopic device for examining or imaging an interior surface of a corporeal cavity |
DE102011107612A1 (en) * | 2011-06-30 | 2013-01-03 | Siegfried Riek | trocar |
WO2013067179A2 (en) * | 2011-11-01 | 2013-05-10 | Synthes Usa, Llc | Dilation system |
US9028522B1 (en) * | 2011-11-15 | 2015-05-12 | Seaspine, Inc. | Tissue dilator and retractor system and method of use |
US9149606B2 (en) * | 2011-12-09 | 2015-10-06 | Teleflex Medical Incorporated | Enhanced introducer assembly |
WO2014013491A1 (en) * | 2012-07-18 | 2014-01-23 | Mor Research Applications Ltd. | Intrauterine device |
CN104883991B (en) * | 2012-09-19 | 2018-08-28 | 南洋理工大学 | Flexible master-slave mode robotic endoscope checks system |
US9078991B2 (en) * | 2013-03-04 | 2015-07-14 | Vascular Solutions, Inc. | Vascular dilator systems, kits, and methods |
US9623220B2 (en) * | 2013-03-14 | 2017-04-18 | The Alfred E. Mann Foundation For Scientific Research | Suture tracking dilators and related methods |
-
2014
- 2014-01-03 US US14/147,345 patent/US9339263B2/en not_active Expired - Fee Related
- 2014-12-24 JP JP2016544408A patent/JP6486945B2/en not_active Expired - Fee Related
- 2014-12-24 AU AU2014374049A patent/AU2014374049B2/en not_active Ceased
- 2014-12-24 WO PCT/US2014/072318 patent/WO2015103066A1/en active Application Filing
- 2014-12-24 EP EP14828421.9A patent/EP3089684B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3089684A1 (en) | 2016-11-09 |
JP6486945B2 (en) | 2019-03-20 |
AU2014374049B2 (en) | 2018-12-13 |
AU2014374049A1 (en) | 2016-07-14 |
US20150190128A1 (en) | 2015-07-09 |
WO2015103066A1 (en) | 2015-07-09 |
JP2017500980A (en) | 2017-01-12 |
US9339263B2 (en) | 2016-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3089684B1 (en) | Dilation system | |
US11737743B2 (en) | Dilation system and method of using the same | |
US11660082B2 (en) | Dilation system | |
US7905884B2 (en) | Method for use of dilating stylet and cannula | |
US8834507B2 (en) | Dilation instruments and methods | |
US7892207B2 (en) | Dilating stylet and cannula | |
AU2012256311A1 (en) | Dilation instruments and methods | |
US11389209B2 (en) | Surgical plating systems, devices, and related methods | |
US8956284B2 (en) | Minimally invasive retractor and posted screw | |
JP6845583B2 (en) | A set with equipment for spinal surgery, belonging guide sleeves, and guide sleeves |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20160621 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20171127 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: CH Ref legal event code: NV Representative=s name: E. BLUM AND CO. AG PATENT- UND MARKENANWAELTE , CH Ref country code: AT Ref legal event code: REF Ref document number: 975682 Country of ref document: AT Kind code of ref document: T Effective date: 20180315 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602014022173 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20180307 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180307 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180307 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180307 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180307 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180607 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180307 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 975682 Country of ref document: AT Kind code of ref document: T Effective date: 20180307 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180307 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180307 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180607 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180608 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180307 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180307 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180307 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180307 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180307 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180307 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180307 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180307 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180307 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180307 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180307 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602014022173 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180709 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180307 |
|
26N | No opposition filed |
Effective date: 20181210 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180307 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180307 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20181224 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20181231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20181224 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20181231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20181231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20181224 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180307 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180307 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20141224 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180707 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20221103 Year of fee payment: 9 Ref country code: DE Payment date: 20220622 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20230101 Year of fee payment: 9 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602014022173 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20231224 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20240702 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231224 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231224 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20240702 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231231 |